News

Genzyme posted a net loss of $114.95m for the first quarter 2010, or $0.43 per diluted share, compared to net income of $195.48m, or $0.70 per diluted share,

Onko-Sure is a simple, non-invasive, patent-pending and regulatory-approved IVD test used for the detection, screening, and monitoring of various types of cancer. The test enables physicians and healthcare

As per the terms of the agreement, Genentech has rights to use Seattle Genetics’ ADC technology with antibodies against targets selected by Genentech. Genentech will be responsible for

Kiobrina is a recombinant human bile-salt-stimulated lipase (rhBSSL) developed to improve growth and development in preterm infants receiving pasteurized breast milk and/or infant formula. The rationale for adding

WaferGen said that the new SmartChip Multi-Sample Dispenser, which is part of the SmartChip Real-Time PCR System, can load up to 384 samples or sample replicates on a

Metoprolol Tartrate is the sixth product being launched under the Strides and Sagent Pharmaceuticals partnership. Metoprolol is the generic equivalent of Novartis pharmaceutical’s Lopressor (Metoprolol Tartarate injection, USP).

Bionovo’s US Patent No 7,700,136 also covers the use of its proprietary Bezielle formulation as a monotherapy for the treatment of breast cancer. The patent is expected to

The acquisition is the next step in Comar’s strategic plan, beginning with the divestiture of its glass vial product line, and focuses on organic growth and acquisitions within

Oxymetazoline Hydrochloride nasal drops, a generic drug, is indicated to treat acute and chronic rhinitis, sinusitis and allergic rhinitis. Moschus Liniment for pain relief is a TCM product